Stoke Therapeutics (STOK) Interest & Investment Income (2022 - 2025)
Historic Interest & Investment Income for Stoke Therapeutics (STOK) over the last 4 years, with Q3 2025 value amounting to $3.5 million.
- Stoke Therapeutics' Interest & Investment Income fell 231.31% to $3.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.1 million, marking a year-over-year increase of 700.24%. This contributed to the annual value of $12.6 million for FY2024, which is 2755.35% up from last year.
- According to the latest figures from Q3 2025, Stoke Therapeutics' Interest & Investment Income is $3.5 million, which was down 231.31% from $3.8 million recorded in Q2 2025.
- In the past 5 years, Stoke Therapeutics' Interest & Investment Income registered a high of $3.8 million during Q2 2025, and its lowest value of $104000.0 during Q1 2022.
- Its 4-year average for Interest & Investment Income is $2.4 million, with a median of $2.6 million in 2023.
- Per our database at Business Quant, Stoke Therapeutics' Interest & Investment Income skyrocketed by 192211.54% in 2023 and then plummeted by 231.31% in 2025.
- Quarter analysis of 4 years shows Stoke Therapeutics' Interest & Investment Income stood at $1.5 million in 2022, then soared by 74.92% to $2.6 million in 2023, then rose by 14.8% to $3.0 million in 2024, then grew by 16.6% to $3.5 million in 2025.
- Its last three reported values are $3.5 million in Q3 2025, $3.8 million for Q2 2025, and $2.9 million during Q1 2025.